Cargando…

A Case Report of Riboflavin Treatment and Cochlear Implants in a 4-Year-Old Girl with Progressive Hearing Loss and Delayed Speech Development: Brown-Vialetto-Van Laere Syndrome

Patient: Female, 4-year-old Final Diagnosis: Brown-Vialetto-Van Laere syndrome Symptoms: Hearing loss auditory neuropathy • delayed speech development • pontobulbar palsy Clinical Procedure: Bilateral cochlear implantation Specialty: Otolaryngology OBJECTIVE: Rare disease BACKGROUND: Brown-Vialetto-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piecuch, Anna K., Skarżyński, Piotr H., Skarżyński, Henryk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560793/ https://www.ncbi.nlm.nih.gov/pubmed/37786244 http://dx.doi.org/10.12659/AJCR.940439

Ejemplares similares

Riboflavin Treatment in Genetically Proven Brown–Vialetto–Van Laere Syndrome
por: Garg, Meenal, et al.
Publicado: (2018)

Cochlear Implant in Brown–Vialetto–Van Laere Syndrome Patient
por: Stella Arantes do Amaral, Maria, et al.
Publicado: (2022)

Brown-Vialetto-Van Laere syndrome
por: Sathasivam, Sivakumar
Publicado: (2008)

Remarkable motor recovery after riboflavin therapy in adult-onset Brown—Vialetto—Van Laere syndrome
por: Bashford, James A, et al.
Publicado: (2017)

Impaired riboflavin transport due to missense mutations in SLC52A2 causes Brown-Vialetto-Van Laere syndrome
por: Haack, Tobias B., et al.
Publicado: (2012)

Madras motor neuron disease (MMND) is distinct from the riboflavin transporter genetic defects that cause Brown–Vialetto–Van Laere syndrome
por: Nalini, Atchayaram, et al.
Publicado: (2013)

Four cases of brown-vialetto-van laere syndrome from Iran: Clinical and electrophysiologic findings
por: Yadegari, Samira, et al.
Publicado: (2011)

Late-onset and acute presentation of Brown-Vialetto-Van Laere syndrome in a Brazilian family
por: Camargos, Sarah, et al.
Publicado: (2018)

A Case of Brown-Vialetto-Van Laere Syndrome Due To a Novel Mutation in SLC52A3 Gene: Clinical Course and Response to Riboflavin
por: Thulasi, Venkatraman, et al.
Publicado: (2017)

Pontobulbar palsy and sensorineural deafness (Brown-Vialetto-van Laere syndrome): A case from Northwest Iran
por: Toopchizadeh, Vahideh, et al.
Publicado: (2013)

The Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: natural history, genetics, treatment and future perspectives
por: Bosch, Annet M, et al.
Publicado: (2012)

A Chinese pedigree with Brown-Vialetto-Van Laere syndrome due to two novel mutations of SLC52A2 gene: clinical course and response to riboflavin
por: Shi, Kaili, et al.
Publicado: (2019)

Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment
por: Bosch, Annet M., et al.
Publicado: (2010)

Multi-Frequency Intraoperative Monitoring of Hearing Preservation during Cochlear Implantation
por: Skarżyński, Piotr Henryk, et al.
Publicado: (2022)

Can an individual with low frequency hearing in the candidate ear benefit from a cochlear implant even if they have normal hearing in the other ear?
por: Lorens, Artur, et al.
Publicado: (2023)

Benefits of Binaural Integration in Cochlear Implant Patients with Single-Sided Deafness and Residual Hearing in the Implanted Ear
por: Lorens, Artur, et al.
Publicado: (2021)

Health-related quality of life in adults with profound postlingual hearing loss before and after cochlear implantation
por: Rostkowska, Joanna, et al.
Publicado: (2021)

First report of paternal uniparental disomy of chromosome 8 with SLC52A2 mutation in Brown-vialetto-van laere syndrome type 2 and an analysis of genotype-phenotype correlations
por: Zhao, Siyu, et al.
Publicado: (2022)

The COVID-19 pandemic and upgrades of CI speech processors for children: part II–hearing outcomes
por: Obrycka, Anita, et al.
Publicado: (2022)

Preservation of Hearing Following Cochlear Implantation Using Different Steroid Therapy Regimens: A Prospective Clinical Study
por: Skarżyńska, Magdalena Beata, et al.
Publicado: (2018)

Vestibular Function After Cochlear Implantation in Partial Deafness Treatment
por: Sosna-Duranowska, Magdalena, et al.
Publicado: (2021)

Prevention of communication disorders – screening pre-school and school-age children for problems with hearing, vision and speech: European Consensus Statement
por: Skarżyński, Henryk, et al.
Publicado: (2012)

The COVID-19 pandemic and upgrades of CI speech processors for children: part I—procedure of speech processor upgrade
por: Obrycka, Anita, et al.
Publicado: (2022)

Resumption of Cochlear Implant Surgery under COVID-19 Pandemic Conditions
por: Skarzynski, Henryk, et al.
Publicado: (2021)

The Oticon Ponto System in Adults With Severe-to-Profound and Mixed Hearing Loss: Audiologic Outcomes and Patient Satisfaction
por: Skarzynski, Piotr Henryk, et al.
Publicado: (2022)

The Clinical Effect of Steroid Therapy on Preserving Residual Hearing after Cochlear Implantation with the Advanced Bionics HiRes Ultra 3D Cochlear Implant System
por: Skarzynska, Magdalena Beata, et al.
Publicado: (2022)

The Genetic Background of Hearing Loss in Patients with EVA and Cochlear Malformation
por: Bałdyga, Natalia, et al.
Publicado: (2023)

Effect on vestibular function of cochlear implantation by partial deafness treatment–electro acoustic stimulation (PDT–EAS)
por: Sosna, Magdalena, et al.
Publicado: (2019)

In Vivo Basilar Membrane Time Delays in Humans
por: Polak, Marek, et al.
Publicado: (2022)

Genome-wide RNA-seq of iPSC-derived motor neurons indicates selective cytoskeletal perturbation in Brown–Vialetto disease that is partially rescued by riboflavin
por: Rizzo, Federica, et al.
Publicado: (2017)

Self-Rated Benefits of Auditory Performance after Bonebridge Implantation in Patients with Conductive or Mixed Hearing Loss, or Single-Sided Deafness
por: Ratuszniak, Anna, et al.
Publicado: (2022)

Prospective cohort study reveals MMP-9, a neuroplasticity regulator, as a prediction marker of cochlear implantation outcome in prelingual deafness treatment
por: Matusiak, Monika, et al.
Publicado: (2022)

Tinnitus in patients with hearing loss due to mitochondrial DNA pathogenic variants
por: Lechowicz, Urszula, et al.
Publicado: (2018)

A Systematic Review of the Literature Between 2009 and 2019 to Identify and Evaluate Publications on the Effects of Age-Related Hearing Loss on Speech Processing
por: de Oliveira Einchner, Andrea Cristina, et al.
Publicado: (2022)

Results of hearing screening of school-age children in Bishkek, Kyrgyzstan
por: Skarżyński, Piotr Henryk, et al.
Publicado: (2020)

Cochlear Implants in Subjects Over Age 65: Quality of Life and Audiological Outcomes
por: Aimoni, Claudia, et al.
Publicado: (2016)

The Clinical Effects of Steroids Therapy in the Preserving Residual Hearing after Cochlear Implantation with the OTICON Neuro Zti EVO
por: Skarzynska, Magdalena B., et al.
Publicado: (2021)

Rates of Vaccination against Streptococcus Pneumoniae in Cochlear Implant Patients
por: Piotrowska, Anna, et al.
Publicado: (2017)

Hearing Preservation With the Use of Flex(20) and Flex(24) Electrodes in Patients With Partial Deafness
por: Skarzynski, Piotr H., et al.
Publicado: (2019)

Functional Polymorphism of MMP9 and BDNF as Potential Biomarker of Auditory Neuroplasticity in Prelingual Deafness Treatment With Cochlear Implantation—A Retrospective Cohort Analysis
por: Matusiak, Monika, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6ah7udg8foafen8jvr5o64uq6j